Clinical Trials
478 trialsEvolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)
UNICANCER
OSIREAL
AstraZeneca
MK-3475-U01
Merck Sharp & Dohme LLC
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Hoffmann-La Roche
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
National Institutes of Health Clinical Center (CC)
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
National Institutes of Health Clinical Center (CC)
Bio-lung
University Hospital, Lille
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
National Institutes of Health Clinical Center (CC)
RACE-2L
AstraZeneca
NAUTIC
AstraZeneca
LUNG-ROLL
AstraZeneca
CHOICE
AstraZeneca
POPPY
University of Sydney
A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)
Ono Pharmaceutical Co., Ltd.
Pan HER2
AstraZeneca
VENTURE
University of Sydney
Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
AstraZeneca
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
Washington University School of Medicine
MYLUNG
US Oncology Research
ALCG-01
Gazi University
CEMI-LUNG
Regeneron Pharmaceuticals
DeniLA
AstraZeneca
A Study in Non-Small Cell Lung Cancer
N-Power Medicine
MAP
AstraZeneca
3D Virtual Resection for Predicting Lung Function in VATS
National Taiwan University Hospital
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes
National Institutes of Health Clinical Center (CC)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
LONGEVITI
University of Alberta
DREAM
AstraZeneca
SHERLOCK
University Health Network, Toronto
NYULCBC
NYU Langone Health
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
LEPIDOPTERA
Janssen Research & Development, LLC
VICTORY 2
Portsmouth Hospitals NHS Trust
4D-MRI for Precision Medicine
University of Virginia
iCaRe2
University of Nebraska
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Hoffmann-La Roche
Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer
University Health Network, Toronto
Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data
University of Utah
Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment
Shanghai Chest Hospital
Evaluation for NCI Surgery Branch Clinical Research Protocols
National Institutes of Health Clinical Center (CC)
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
National Institutes of Health Clinical Center (CC)
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
University of Missouri-Columbia
DP-04
AstraZeneca
OMIM
Azienda USL Reggio Emilia - IRCCS
E20241186
Tianjin Medical University Cancer Institute and Hospital
OMAE
Groupe Francais De Pneumo-Cancerologie
BASECAMP-1
A2 Biotherapeutics Inc.
Shared Decision Making in Patients With Lung Cancer
Sichuan Cancer Hospital and Research Institute